Science Explorer Back to mapMap
Discussion
Researcher · KU Leuven · Belgium

Patrick Schöffski

Patrick Schöffski publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Gastroenterology, on topics such as Sarcoma Diagnosis and Treatment, Gastrointestinal Tumor Research and Treatment and Gastric Cancer Management and Outcomes.

ORCID 0000-0001-5980-030X OpenAlex
World rank
#67,338
of 7,710,434 ranked researchers
Rank in Belgium
#360
of 67,186
Works
1,167
Citations
45k
Citations per work
38.7
h-index
94
i10-index 375Top 0.2% in Pulmonary and Respiratory Medicine
Patrick Schöffski

What does Patrick Schöffski research?

Patrick Schöffski's work is mostly in Medicine (58%), Biochemistry, Genetics and Molecular Biology (13%).

Health Sciences: 673 works · 57.7% of their workMedicine: 673 works · 57.7% of their workPulmonary and Respiratory Medicine: 278 works · 23.8% of their workOncology: 196 works · 16.8% of their workGastroenterology: 119 works · 10.2% of their workSurgery: 81 works · 6.9% of their workEverything else: 342 works · 29.3% of their workLife Sciences: 152 works · 13.0% of their workBiochemistry, Genetics and Molecular Biology: 152 works · 13.0% of their workMolecular Biology: 99 works · 8.5% of their workCancer Research: 53 works · 4.5% of their workTHEIR WORKPatrick Schöffski1,167works
Life Sciences13%Health Sciences58%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine67357.7%
  2. Everything else34229.3%
    1. Biochemistry, Genetics and Molecular Biology15213.0%
  1. 1Pulmonary and Respiratory Medicine24% of their works
  2. 2Oncology17% of their works
  3. 3Gastroenterology10% of their works
  4. 4Molecular Biology8% of their works
  5. 5Surgery7% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Patrick Schöffski's research?

The keywords of their largest research topics: Prognostic Factors, Chemotherapy, Clinical Practice Guidelines, Osteosarcoma, Soft Tissue Sarcoma, Imatinib Mesylate, Sunitinib and Molecular Characterization.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Prognostic Factors4923 topics
  2. Chemotherapy3082 topics
  3. Clinical Practice Guidelines3082 topics
  4. Osteosarcoma2311 topic
  5. Soft Tissue Sarcoma2311 topic
  6. Imatinib Mesylate1921 topic
  7. Sunitinib1921 topic
  8. Molecular Characterization1462 topics
  9. Targeted Therapy992 topics
  10. Endoscopic Resection771 topic
  11. Gastric Cancer771 topic
  12. Metastatic691 topic
  13. Renal Cell Carcinoma691 topic
  14. ALK Inhibitors531 topic
  15. EGFR Mutations531 topic
  16. Angiosarcoma511 topic
  17. Epithelioid Hemangioendothelioma511 topic
  18. Chemotherapy-Induced Peripheral Neuropathy481 topic
  19. Taxanes481 topic
  20. Cancer Genomics461 topic
  21. Mutational Signatures461 topic

Where does Patrick Schöffski work?

Patrick Schöffski's main affiliation in the publication record is KU Leuven, Belgium.

How many publications and citations does Patrick Schöffski have?

OpenAlex counts 1,167 works and 45,184 citations for Patrick Schöffski, an h-index of 94, ranking #67,338 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Patrick Schöffski. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.